Record FY25: Supreme PLC hits £231.1m revenue & £40.5m EBITDA. Strategic buys of Typhoo Tea & Clearly Drinks drive diversification & growth. Analysis inside.
This article covers information on Supreme PLC.
LON:SUPSupreme PLC’s latest financials tell a compelling story of strategic reinvention. While a 6% jump in Adjusted EBITDA to £40.5m and 4% revenue growth to £231.1m are impressive on their own, the real narrative lies in how they’ve navigated regulatory headwinds and diversified their portfolio. The acquisitions of Typhoo Tea and Clearly Drinks weren’t just box-ticking exercises – they’ve fundamentally reshaped the group’s earnings profile, adding £40m of annualised non-vape revenue almost overnight.
Let’s crack open the headline numbers:
Supreme’s M&A playbook deserves study. They’re not chasing vanity projects – they’re hunting neglected assets with turnaround potential, leveraging their distribution muscle:
Snapped up for just £10.2m from administration, this iconic brand had been mismanaged into £4.6m losses. Supreme’s already stabilised it, achieving £6.1m revenue and positive EBITDA contribution within four months. The plan? Reignite mainstream distribution, bring manufacturing back in-house, and exploit cross-selling across their 10,000+ retail outlets.
The £15.6m acquisition wasn’t just about brands – it was about capabilities. That 150,000 sq ft automated facility is a platform for new product development (think protein-infused wellness drinks). Crucially, they’ve already secured listings for Clearly’s brands with major existing clients – synergy in action.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
53 viewsLikes
No ratings yet
Enjoying this?
Occasional emails on automation, AI and finance. Unsubscribe any time.
Yes, the UK disposable vape ban clipped revenues (£54.1m vs £70.7m). But look deeper: non-disposable vape sales grew 8%, and margins expanded. Supreme saw this coming, managed stock brilliantly (avoiding nasty write-downs), and is now a government advisor on vaping taxation. Their pod and rechargeable transition? Executed with military precision.
Revenue doubled to £48.8m. Sci-MX (acquired for £1.4m in FY22, now delivering £10m revenue) exemplifies Supreme’s brand revival magic. Combining this with Typhoo and Clearly Drinks creates a formidable category – expect serious cross-selling fireworks in FY26.
A 6% revenue dip to £53.4m reflects a tough market, but it remains a reliable cash generator. Supreme’s outperforming the sector decline – a testament to their retailer relationships and logistical edge.
Management’s guidance is refreshingly clear: FY26 trading in line with consensus (£236m revenue, £36.5m EBITDA). The focus is clear:
Supreme’s transformation is palpable. They’ve deftly handled a regulatory earthquake in vaping while simultaneously building a diversified, brand-led FMCG platform with serious manufacturing clout. The record results are impressive, but the strategic repositioning is what truly excites. Trading on a PER just north of 12x? For a business with this growth trajectory and M&A optionality, that feels like a potential mispricing. One to watch closely as the drinks and wellness integration plays out.
Chadha and team are playing chess, not checkers. Their next move should be fascinating.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.